Thomas Ernst
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 96
- Chronic Myeloid Leukemia Treatments 70
- Acute Myeloid Leukemia Research 31
- Genetics 62
- Chronic Lymphocytic Leukemia Research 44
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
- Co-authors
- Andreas Hochhaus (100 shared papers)Nicholas C.P. Cross (27 shared papers)Oliver Speck (3 shared papers)Maria Leonido–Yee (2 shared papers)Andrew Chase (11 shared papers)Andreas Reiter (13 shared papers)Claire Hidalgo-Curtis (9 shared papers)Katerina Zoi (8 shared papers)
- Journals
- Blood (26 papers)Leukemia (20 papers)Journal of Cancer Research and Clinical Oncology (14 papers)Haematologica (7 papers)Cancers (5 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Thomas Ernst
156 papers receiving 5.9k citations
Thomas Ernst's Hit Papers
Peers
Comparison fields: 5 of 133
- Hematology 2.8k
- Genetics 1.9k
- Rheumatology 807
- Hepatology 289
- Toxicology 126
Countries citing papers authored by Thomas Ernst
This map shows the geographic impact of Thomas Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ernst more than expected).
Fields of papers citing papers by Thomas Ernst
This network shows the impact of papers produced by Thomas Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ernst. The network helps show where Thomas Ernst may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Ernst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Hit paper breakdown → | 2010 | 812 |
| 2 | 2011 | 373 | |
| 3 | 2000 | 305 | |
| 4 | 2009 | 273 | |
| 5 | 2002 | 215 | |
| 6 | 2011 | 201 | |
| 7 | 2003 | 188 | |
| 8 | 1999 | 174 | |
| 9 | 2004 | 173 | |
| 10 | 2019 | 171 | |
| 11 | 1994 | 161 | |
| 12 | 2008 | 155 | |
| 13 | 2009 | 140 | |
| 14 | 2011 | 125 | |
| 15 | 2018 | 92 | |
| 16 | 2014 | 89 | |
| 17 | 2019 | 88 | |
| 18 | 2008 | 85 | |
| 19 | 2016 | 84 | |
| 20 | 2013 | 80 |
About Thomas Ernst
Thomas Ernst is a scholar working on Hematology, Genetics, Molecular Biology, Rheumatology and Oncology, having authored 166 papers that have together received 6.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (70 papers), Chronic Lymphocytic Leukemia Research (44 papers), Acute Myeloid Leukemia Research (31 papers), Eosinophilic Disorders and Syndromes (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (15 papers), Head and Neck Cancer Studies (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (2.8k citations), Genetics (1.9k citations), Rheumatology (807 citations), Hepatology (289 citations) and Toxicology (126 citations). Thomas Ernst has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Andreas Hochhaus, Nicholas C.P. Cross, Oliver Speck, Maria Leonido–Yee, Andrew Chase, Andreas Reiter, Claire Hidalgo-Curtis, Katerina Zoi, Amy V. Jones and Linda Chang. Their work appears in journals such as Blood, Leukemia, Journal of Cancer Research and Clinical Oncology, Haematologica and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.